The Viveve® System is a dual-energy platform device. It incorporates Cryogen-cooled Monopolar Radiofrequency technology (CMRF) to uniformly deliver volumetric heating while gently cooling surface tissue in a single in-office session. Viveve’s procedure is performed in approximately 45 minutes and requires no anesthesia to maintain patient comfort.

shield

Unique Clinical Value

  • First in class Mechanism of Action
  • Strong body of clinical evidence
  • Favorable clinical outcomes
microscope

Treatment Features

  • Non-invasive
  • Single session treatment
  • No anesthesia required
  • Zero downtime

Understanding the Science

For additional information, please visit our clinical studies page where you’ll find the latest on our Pre-Clinical Studies, as well as Randomized, Blinded, Controlled Clinical Studies.

Interested in learning more about Viveve?

Request to be Contacted

Product Indications

Viveve System
The Viveve System is indicated for general surgery for electrocoagulation and hemostasis in the United States.
Viveve Solutions
The Viveve System is indicated for general surgery for electrocoagulation and hemostasis in the United States. The InControl Products (InToneMV) is indicated for the treatment of all forms of urinary incontinence in the United States and Canada.